Jamie D Knight - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Organic Letters|February 12, 2005

Oxaziridine-mediated amination of primary amines: scope and application to a one-pot pyrazole synthesisAlan Armstrong, Lyn H Jones, Jamie D Knight, et al.

Chemical Communications (Cambridge, England)|September 26, 2002

Synthesis and structural analysis of dehydrophenylalanine cyclophanesSusan E Gibson, Jerome O Jones, S Barret Kalindjian, et al.

Journal of Medicinal Chemistry|August 27, 2016

Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.

Journal of Medicinal Chemistry|December 1, 2022

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3KαEmily J Hanan, Marie-Gabrielle Braun, Robert A Heald, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Organic Letters|February 12, 2005

Oxaziridine-mediated amination of primary amines: scope and application to a one-pot pyrazole synthesisAlan Armstrong, Lyn H Jones, Jamie D Knight, et al.

Chemical Communications (Cambridge, England)|September 26, 2002

Synthesis and structural analysis of dehydrophenylalanine cyclophanesSusan E Gibson, Jerome O Jones, S Barret Kalindjian, et al.

Journal of Medicinal Chemistry|August 27, 2016

Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor InhibitorBryan K Chan, Emily J Hanan, Krista K Bowman, et al.

Journal of Medicinal Chemistry|December 1, 2022

Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3KαEmily J Hanan, Marie-Gabrielle Braun, Robert A Heald, et al.

Pageof 1